Utility of the Evaluation of Blood Flow of the Remnant Esophagus in

Status Completed

Clinical Trial Summary

Pedicled jejunal flap can be utilized with various tips for esophageal reconstruction in patients with a history of gastrectomy, or those who have undergone synchronous esophagogastrectomy, although the rate of anastomosis leakage is high with this technique. Therefore, in the current study, we considered the utility of the evaluation of blood flow of the remnant esophagus with indocyanine green in setting the anastomosis site. We included 50 patients who underwent radical esophagectomy with pedicled jejunal flap between April 2012 and June 2020. From June 2019, the blood flow of not only the pedicled jejunum, but also the remnant esophagus were evaluated in order to set the anastomosis site of the latter because the color was not definitive criteria for judging in surgery on the remnant esophagus. Usually, the second and third jejunal vessels are transected, and if the jejunal flap cannot reach to the anastomosis point, we actively transect the marginal vessels in order to stretch the jejunal flap. Microvascular anastomosis between the jejunal branches (the second) and the internal thoracic vessels is usually made, and the anastomosis site is set at the part of the esophagus that is well-dyed with indocyanine green. A total of 39 patients underwent the procedure prior to June 2019 ( Group A), and 11 patients underwent the procedure as of June 2019 (Group B). No significant difference was found in the patients' background, type of preoperative therapy, and presence or absence of ligation of marginal vessels and two-stage operation between the two groups. Group A had 16 cases of anastomosis leakage, while Group B only has one (P < 0.05). There were no cases of significant pedicled jejunum graft necrosis. Our findings demonstrate that the evaluation of the blood flow of the remnant esophagus during setting of the anastomosis site may decrease the rate of anastomosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Esophagectomy

Clinical Trial Details

NCT number	NCT04597398
Study type	Observational
Source	Shizuoka Cancer Center
Contact
Status	Completed
Phase
Start date	April 1, 2012
Completion date	July 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00827931` - Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery	Phase 4
Completed	`NCT00420017` - Prevention of Atrial Fibrillation Following Esophagectomy	Phase 4
Recruiting	`NCT04750096` - Esophagectomy Enhanced Recovery After Surgery Protocol
Not yet recruiting	`NCT06147180` - Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
Active, not recruiting	`NCT03740542` - Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy	N/A
Recruiting	`NCT03835273` - Oesophagectomy and Chest Wall and Respiratory Function
Enrolling by invitation	`NCT02086461` - Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay	N/A
Recruiting	`NCT00260559` - Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Recruiting	`NCT02017002` - Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer	N/A
Recruiting	`NCT04654975` - Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
Recruiting	`NCT04008420` - The Association of Intraoperative Oxygen Reserve Index and Postoperative Pulmonary Complications in Robot-assisted Esophagectomy
Recruiting	`NCT01144325` - Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus Position	Phase 2
Completed	`NCT01169051` - A Retrospective Analysis of Statin Use and Outcome After Thoracic Cancer Surgery	N/A
Recruiting	`NCT05950438` - Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
Not yet recruiting	`NCT06271707` - Stellate Ganglion Block	Phase 4
Recruiting	`NCT02418052` - Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE	N/A
Completed	`NCT02158286` - Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet	N/A
Recruiting	`NCT02309619` - Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE	N/A
Completed	`NCT05604950` - Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years
Completed	`NCT00708513` - Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Utility of the Evaluation of Blood Flow of the Remnant Esophagus in Esophagectomy With Pedicled Jejunum Reconstruction

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms